MAKO Surgical Corp.’s innovative robotic arm technology empowers the MAKOplasty® advantage for knee and hip procedures. The RIO® Robotic Arm Interactive Orthopedic System and enabling RESTORIS® implant designs, allow surgeons to achieve a new level of accuracy, precision, and confidence to patient-specific treatment of painful knee and hip conditions that may restore patient mobility and an active lifestyle.

Patents 661show all

  • 212
    A61B - Diagnosis
  • 106
    A61F - Filters implantable into blood vessels
  • 30
    B25J - Manipulators
  • 28
    G16H - Healthcare informatics, i.e. information and communication technology [ict] specially adapted for the handling or processing of medical or healthcare data
  • 26
    G06F - Electric digital data processing
  • 20
    G05B - Control or regulating systems in general
  • 17
    G06T - Image data processing or generation, in general
  • 12
    G09B - Educational or demonstration appliances
  • 10
    B62B - Hand-propelled vehicles, e.g. hand carts, perambulators
  • 7
    G02B - Optical elements, systems, or apparatus

Clinical Trials 2show all

1N/A

SEC Filings show all


65
8-K

18
10-Q

6
10-K

1
S-1

Contact Information

2555 Davie Road
Fort Lauderdale, FL 33317
United States

Overview

Total FundingEmployeesLast Funding DateStatus
$94,700,000251-5002008-10-31Acquired

Crunchbase Investment Rounds

DateAmountRoundValuationLead InvestorOther Investors
2005-04-25$4,600,000Series ASycamore Ventures
2005-08-08$20,000,000Series BIvy Capital Partners, MDS Capital, Aperture Venture Partners, Sycamore Ventures, The Exxel Group
2008-10-31$40,000,000Post Ipo EquityZiegler Meditech Equity Partners
2008-02-07$100,000Post Ipo EquityZiegler Meditech Equity Partners
2007-02-06$30,000,000Series CTudor InvestmentsAperture Venture Partners, Sycamore Ventures, The Exxel Group, Ziegler Meditech Equity Partners, Ivy Capital Partners, MDS Capital